LBA72 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial
M.F. Mosele, Amélie Lusque, Véronique Dièras, Élise Deluche, Agnès Ducoulombier, Barbara Pistilli, T. Bachelot, F. Viret, C. Lévy, Y.C. Pradat, Dien Tran, Nathalie Droin, Michihiko Kobayashi, T. Kakewaga, Marc Deloger, Bastien Job, Marta Jimenez, M. Lacroix-Triki, Fabrice André
Topics & Concepts
MedicineBiomarkerTrastuzumabInternal medicineOncologyBreast cancerCancerChemistryBiochemistryAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies